Taro Pharmaceutical Indus
(NYSE:TARO)
$42.45
-0.06[-0.14%]
At close: May 3
$42.45
0[0.00%]
After Hours: 4:00PM EDT
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest

Taro Pharmaceutical Indus Stock (NYSE:TARO), Quotes and News Summary

Taro Pharmaceutical Indus Stock (NYSE: TARO) stock price, news, charts, stock research, profile.

Open$42.480
Close$42.450
Volume / Avg.24.727K / 43.883K
Day Range42.340 - 42.620
52 Wk Range25.220 - 45.760
Market Cap$1.595B
P/E Ratio34.844
Dividend Yield-
ExchangeNYSE
RSI
0
Short Interest
0.49%
Days to Cover1.27

Recent News

Why Nvidia Shares Are Trading Higher By Over 5%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers QualTek Services Inc. (NASDAQ: QTEK) shares jumped 127.2% to $0.1740 after dropping around 21% on Friday. Qualtek Services recently filed voluntarily petitions for Chapter 11 bankruptcy.
Lisa Levin
Daily Biotech Pulse: Teva's Opioids Settlement, Criminal Investigation Against Cassava, Durable Responses For IN8bio's Leukemia Therapy
Here's a roundup of top developments in the biotech space over the last 24 hours:
Vandana Singh
The Week Ahead In Biotech (May 22-28): Verrica, Bristol-Myers Squibb FDA Decisions, Medtronic Earnings, Conference Presentations & More
Biotech stocks advanced in the week ending May 22, defying the broader market retreat. The defensive nature of the industry and stock-specific moves lent support.
Shanthi Rexaline
-%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
1
Jan
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
3.0
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell

Compare

EPS better than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
TARO

FAQ

Q

How do I buy Taro Pharmaceutical Indus (TARO) stock?

A

You can purchase shares of Taro Pharmaceutical Indus (NYSE: TARO) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Taro Pharmaceutical Indus's (TARO) competitors?

A

There are no as such competitors for Taro Pharmaceutical Indus.

Q

What is the target price for Taro Pharmaceutical Indus (TARO) stock?

A

The latest price target for Taro Pharmaceutical Indus (NYSE: TARO) was reported by HC Wainwright & Co. on Thursday, January 18, 2024. The analyst firm set a price target for 43.00 expecting TARO to rise to within 12 months (a possible 1.30% upside). 1 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Taro Pharmaceutical Indus (TARO)?

A

The stock price for Taro Pharmaceutical Indus (NYSE: TARO) is $42.45 last updated Today at May 3, 2024 at 4:00 PM EDT.

Q

Does Taro Pharmaceutical Indus (TARO) pay a dividend?

A

A quarterly cash dividend of $12.81 per share of Class A Common Stock. The quarterly cash dividend was payable on December 28, 2018 to stockholders of record on December 10, 2018.

Q

When is Taro Pharmaceutical Indus (NYSE:TARO) reporting earnings?

A

Taro Pharmaceutical Indus’s Q1 earnings are confirmed for Wednesday, July 24, 2024.

Q

Is Taro Pharmaceutical Indus (TARO) going to split?

A

There is no upcoming split for Taro Pharmaceutical Indus.

Q

What sector and industry does Taro Pharmaceutical Indus (TARO) operate in?

A

Taro Pharmaceutical Indus is in the Healthcare sector and Drug Manufacturers—Specialty & Generic industry. They are listed on the NYSE.